---
schema_version: "secwatch.filing_event.v1"
accession: "0000875320-26-000278"
form_type: "8-K"
ticker: "VRTX"
cik: "0000875320"
company_name: "VERTEX PHARMACEUTICALS INC / MA"
filed_at: "2026-10-20T20:09:27+00:00"
generated_at: "2026-10-20T20:10:02.598687+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Vertex appoints ex-Boston Scientific CFO Daniel Brennan to board; board expands to 11 members

## Summary
- Daniel Brennan appointed to Vertex's board of directors on October 20, 2026, expanding the board from ten to eleven members.
- Brennan also joins the Audit and Finance Committee; he retired in June 2025 as EVP and CFO of Boston Scientific, where he served from January 2014.
- Brennan sits on boards of Waters Corporation (since November 2022) and Madrigal Pharmaceuticals (since August 2025); previously on Nuance's board until its 2022 Microsoft acquisition.
- Received a $400,000 restricted stock unit award upon joining, vesting in October 2027; Vertex reports no Item 404(a) related-party transactions.

## SEC filing metadata
- accession: 0000875320-26-000278
- form_type: 8-K
- ticker: VRTX
- cik: 0000875320
- company_name: VERTEX PHARMACEUTICALS INC / MA
- filed_at: 2026-10-20T20:09:27+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/875320/000087532026000278/0000875320-26-000278-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/875320/000087532026000278/vrtx-20261020.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000875320-26-000278
- JSON: https://secwatch.observer/filing/0000875320-26-000278.json
- Plain text: https://secwatch.observer/filing/0000875320-26-000278.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.